| Oct 31 |
Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024
|
| Oct 25 |
Xeris Biopharma Holdings: Promising Pipeline And Strategic Partnerships Make It Attractive
|
| Oct 9 |
Several Insiders Invested In Xeris Biopharma Holdings Flagging Positive News
|
| Oct 9 |
Xeris Biopharma: Time For A Reassessment
|
| Sep 25 |
Zevra Therapeutics (ZVRA) Moves 9.1% Higher: Will This Strength Last?
|
| Sep 12 |
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) most popular amongst individual investors who own 53% of the shares, institutions hold 43%
|
| Aug 22 |
Xeris to Participate in Upcoming Investor Conferences
|
| Aug 14 |
More Than $20M Bet On Precigen? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying
|
| Aug 13 |
Xeris Biopharma And 2 Other Penny Stocks Insiders Are Buying
|
| Aug 8 |
Xeris Biopharma Holdings, Inc. (XERS) Q2 2024 Earnings Call Transcript
|
